N. L. Fox
Impact in
- Hematology top 1%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Cancer Research and Treatments 7
- Rheumatology 10
- Systemic Lupus Erythematosus Research 8
- Co-authors
- Kenneth KaushanskyN LinVC BroudyNS WolfEwa SitnickaJohn M. McCartyV C BroudyCatherine Lofton–Day
- Journals
- Journal of Clinical Oncology (12 papers)Annals of the Rheumatic Diseases (7 papers)Blood (3 papers)Annals of Oncology (2 papers)Lupus (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
N. L. Fox
36 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 83
- Hematology 695
- Genetics 233
- Immunology 341
- Cancer Research 149
- Oncology 249
Countries citing papers authored by N. L. Fox
This map shows the geographic impact of N. L. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. L. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. L. Fox more than expected).
Fields of papers citing papers by N. L. Fox
This network shows the impact of papers produced by N. L. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. L. Fox. The network helps show where N. L. Fox may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N. L. Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2022 | 2 | |
| 3 | 2021 | 1 | |
| 4 | 2016 | 1 | |
| 5 | 2016 | 39 | |
| 6 | 2015 | 1 | |
| 7 | 2010 | 112 | |
| 8 | 2009 | 2 | |
| 9 | 2009 | 120 | |
| 10 | 2007 | 42 | |
| 11 | 2006 | 14 | |
| 12 | 2005 | 19 | |
| 13 | 2004 | 20 | |
| 14 | 2004 | 10 | |
| 15 | 2004 | 8 | |
| 16 | Targeting adolescent mothers with depressive symptoms for early intervention. | 2000 | 76 |
| 17 | 1999 | 76 | |
| 18 | 1996 | 288 | |
| 19 | 1995 | 165 | |
| 20 | 1987 | 11 |
About N. L. Fox
N. L. Fox is a scholar working on Biotechnology, Rheumatology, Hematology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (11 papers), Systemic Lupus Erythematosus Research (8 papers), Cancer Research and Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Lung Cancer Treatments and Mutations (6 papers), Platelet Disorders and Treatments (4 papers), Peripheral Neuropathies and Disorders (3 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Hematology (695 citations), Genetics (233 citations), Immunology (341 citations), Cancer Research (149 citations) and Oncology (249 citations). N. L. Fox has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Kenneth Kaushansky, N Lin, VC Broudy, NS Wolf, Ewa Sitnicka, John M. McCarty, V C Broudy, Catherine Lofton–Day, M J Jorgensen and R. Miceli. Their work appears in journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases, Blood, Annals of Oncology and Lupus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.